{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:42:28Z","timestamp":1791222148789,"version":"4.1.0"},"reference-count":25,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Shanxi Provincial Key Research and Development Project, China","award":["202102140601019"],"award-info":[{"award-number":["202102140601019"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Porcine recombinant NK-lysin (prNK-lysin) has been shown to inhibit the proliferation and metastasis of hepatocellular carcinoma (HCC) cells in vitro. However, its effects on the proliferation and metastasis of HCC cells in vivo remain unclear. In this study, an allograft murine model using the murine HCC cell line Hepa1-6 was employed to investigate the anticancer effects of prNK-lysin. Initially, the in vitro anticancer efficacy of prNK-lysin was evaluated in Hepa1-6 cells, demonstrating that prNK-lysin effectively inhibited both proliferation and metastasis. These effects were mediated through the induction of oncosis and suppression of Fascin-1, MMP-2, and MMP-9 protein expressions. Subsequently, the in vivo anticancer efficacy of prNK-lysin was assessed using a mouse liver orthotopic implantation model and a lung metastasis model of Hepa1-6 cells in BALB\/cA-nu mice. The administration of 13 mg\/kg of prNK-lysin could inhibit tumor growth in the liver and metastasis to the lungs. Our results demonstrate that prNK-lysin possesses strong anti-HCC effects both in vitro and in vivo, with the induction of oncosis and the inhibition of Fascin-1, MMP-2, and MMP-9 protein expressions as potential molecular mechanisms for its anticancer activity.<\/jats:p>","DOI":"10.3390\/molecules30061234","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T05:46:52Z","timestamp":1741585612000},"page":"1234","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Porcine Recombinant NK-Lysin Inhibits the Growth and Metastasis of Murine Hepatocellular Carcinoma In Vivo"],"prefix":"10.3390","volume":"30","author":[{"given":"Kuohai","family":"Fan","sequence":"first","affiliation":[{"name":"Shanxi Key Laboratory for Modernization of TCVM, College of Veterinary Medicine, Shanxi Agricultural University, Taigu 030801, China"},{"name":"Laboratory Animal Center, Shanxi Agricultural University, Taigu 030801, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Feng","sequence":"additional","affiliation":[{"name":"Shanxi Key Laboratory for Modernization of TCVM, College of Veterinary Medicine, Shanxi Agricultural University, Taigu 030801, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahai","family":"Zhao","sequence":"additional","affiliation":[{"name":"Shanxi Key Laboratory for Modernization of TCVM, College of Veterinary Medicine, Shanxi Agricultural University, Taigu 030801, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhong","family":"Zheng","sequence":"additional","affiliation":[{"name":"Shanxi Key Laboratory for Modernization of TCVM, College of Veterinary Medicine, Shanxi Agricultural University, Taigu 030801, China"},{"name":"Medical Research Council (MRC) Centre for Inflammation Research, Queen\u2019s Medical Research Institute, The University of Edinburgh, Edinburgh EH16 4TJ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yin","sequence":"additional","affiliation":[{"name":"Shanxi Key Laboratory for Modernization of TCVM, College of Veterinary Medicine, Shanxi Agricultural University, Taigu 030801, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Sun","sequence":"additional","affiliation":[{"name":"Shanxi Key Laboratory for Modernization of TCVM, College of Veterinary Medicine, Shanxi Agricultural University, Taigu 030801, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panpan","family":"Sun","sequence":"additional","affiliation":[{"name":"Shanxi Key Laboratory for Modernization of TCVM, College of Veterinary Medicine, Shanxi Agricultural University, Taigu 030801, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongquan","family":"Li","sequence":"additional","affiliation":[{"name":"Shanxi Key Laboratory for Modernization of TCVM, College of Veterinary Medicine, Shanxi Agricultural University, Taigu 030801, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Gabbia, D., and De Martin, S. (2024). Insights into Hepatocellular Carcinoma: From Pathophysiology to Novel Therapies. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25084188"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Sun, L.Y., Zhang, K.J., Xie, Y.M., Liu, J.W., and Xiao, Z.Q. (2023). Immunotherapies for advanced hepatocellular carcinoma. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1138493"},{"key":"ref_3","first-page":"1391","article-title":"Progress in the mechanisms of anticancer peptides","volume":"35","author":"Qiao","year":"2019","journal-title":"Chin. J. Biotechnol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Karami Fath, M., Babakhaniyan, K., Zokaei, M., Yaghoubian, A., Akbari, S., Khorsandi, M., Soofi, A., Nabi-Afjadi, M., Zalpoor, H., and Jalalifar, F. (2022). Anti-cancer peptide-based therapeutic strategies in solid tumors. Cell. Mol. Biol. Lett., 27.","DOI":"10.1186\/s11658-022-00332-w"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/02648725.2022.2082157","article-title":"Anti-cancer peptides: Their current trends in the development of peptide-based therapy and anti-tumor drugs","volume":"39","author":"Lath","year":"2023","journal-title":"Biotechnol. Genet. Eng. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Qu, B., Yuan, J., Liu, X., Zhang, S., Ma, X., and Lu, L. (2024). Anticancer activities of natural antimicrobial peptides from animals. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1321386"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Chinnadurai, R.K., Khan, N., Meghwanshi, G.K., Ponne, S., Althobiti, M., and Kumar, R. (2023). Current research status of anti-cancer peptides: Mechanism of action, production, and clinical applications. Biomed. Pharmacother., 164.","DOI":"10.1016\/j.biopha.2023.114996"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/j.1460-2075.1995.tb07150.x","article-title":"NK-lysin, a novel effector peptide of cytotoxic T and NK cells. Structure and cDNA cloning of the porcine form, induction by interleukin 2, antibacterial and antitumour activity","volume":"14","author":"Andersson","year":"1995","journal-title":"EMBO J."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Ortega, L., Carrera, C., Mu\u00f1oz-Flores, C., Salazar, S., Villegas, M.F., Starck, M.F., Valenzuela, A., Agurto, N., Montesino, R., and Astuya, A. (2024). New insight into the biological activity of Salmo salar NK-lysin antimicrobial peptides. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1191966"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Lin, Q., Fu, Q., Chen, D., Yu, B., Luo, Y., Huang, Z., Zheng, P., Mao, X., Yu, J., and Luo, J. (2021). Functional Characterization of Porcine NK-Lysin: A Novel Immunomodulator That Regulates Intestinal Inflammatory Response. Molecules, 26.","DOI":"10.3390\/molecules26144242"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/10826068.2014.979206","article-title":"Expression and purification of the recombinant porcine NK-lysin in Pichia pastoris and observation of anticancer activity In Vitro","volume":"46","author":"Fan","year":"2016","journal-title":"Prep. Biochem. Biotechnol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.ijbiomac.2019.08.212","article-title":"Recombinant porcine NK-lysin inhibits the invasion of hepatocellular carcinoma cells In Vitro","volume":"140","author":"Khan","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.advms.2023.08.003","article-title":"Fascin in migration and metastasis of breast cancer cells\u2014A review","volume":"68","author":"Izdebska","year":"2023","journal-title":"Adv. Med. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.4049\/jimmunol.161.4.1758","article-title":"Granulysin-induced apoptosis. I. Involvement of at least two distinct pathways","volume":"161","author":"Gamen","year":"1998","journal-title":"J. Immunol."},{"key":"ref_15","first-page":"3","article-title":"Apoptosis, oncosis, and necrosis. An overview of cell death","volume":"146","author":"Majno","year":"1995","journal-title":"Am. J. Pathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1471-4159.1992.tb08910.x","article-title":"Cell swelling, blebbing, and death are dependent on ATP depletion and independent of calcium during chemical hypoxia in a glial cell line (ROC-1)","volume":"59","author":"Altschuld","year":"1992","journal-title":"J. Neurochem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e2004566","DOI":"10.1002\/advs.202004566","article-title":"A Continuous Add-On Probe Reveals the Nonlinear Enlargement of Mitochondria in Light-Activated Oncosis","volume":"8","author":"Wang","year":"2021","journal-title":"Adv. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/019262339702500116","article-title":"The pathways of cell death: Oncosis, apoptosis, and necrosis","volume":"25","author":"Trump","year":"1997","journal-title":"Toxicol. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/1097-0320(20010501)44:1<65::AID-CYTO1083>3.0.CO;2-Q","article-title":"Oncosis is associated with exposure of phosphatidylserine residues on the outside layer of the plasma membrane: A reconsideration of the specificity of the annexin V\/propidium iodide assay","volume":"44","author":"Lecoeur","year":"2001","journal-title":"Cytometry"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"9778","DOI":"10.1073\/pnas.171322898","article-title":"Molecular cloning of Porimin, a novel cell surface receptor mediating oncotic cell death","volume":"98","author":"Ma","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4161\/cib.3.3.11556","article-title":"Fascin: Invasive filopodia promoting metastasis","volume":"3","author":"Machesky","year":"2010","journal-title":"Commun. Integr. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.3892\/mmr.2020.11592","article-title":"MicroRNA-145-5p suppresses fascin to inhibit the invasion and migration of cervical carcinoma cells","volume":"22","author":"He","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1002\/jcb.27638","article-title":"Leucine aminopeptidase 3 promotes migration and invasion of breast cancer cells through upregulation of fascin and matrix metalloproteinases-2\/9 expression","volume":"120","author":"Fang","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Tan, V.Y., Lewis, S.J., Adams, J.C., and Martin, R.M. (2013). Association of fascin-1 with mortality, disease progression and metastasis in carcinomas: A systematic review and meta-analysis. BMC Med., 11.","DOI":"10.1186\/1741-7015-11-52"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1016\/j.bmcl.2016.07.004","article-title":"Timosaponin AIII inhibits migration and invasion of A549 human non-small-cell lung cancer cells via attenuations of MMP-2 and MMP-9 by inhibitions of ERK1\/2, Src\/FAK and \u03b2-catenin signaling pathways","volume":"26","author":"Jung","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/6\/1234\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:49:50Z","timestamp":1760028590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/6\/1234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["molecules30061234"],"URL":"https:\/\/doi.org\/10.3390\/molecules30061234","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]}}}